Sign in →

Test Code PROPX PROPOXYPHENE SCREEN WITH GC-MS CONFIRMATION, URINE

Additional Codes

Software Test Code
Label Text                                   PROPX
EPIC LAB10899                                          

Performing Laboratory

NorDx Laboratories

Useful For

Detecting propoxyphene in urine

Method Name

Enzyme Immunoassay (EIA)

Gas Chromatography-Mass Spectrometry (GC-MS) (If indicated)

Reference Values

Not Detected

EIA cutoff concentration: 300 ng/mL

GC-MS cutoff concentration:

Norpropoxyphene: <60 ng/mL

For help with interpretation please call: 877-323-0045

Days and Times Test Performed

Monday through Friday

Report Available

1 Day

Specimen Type

Urine, Random

Preferred Container

Urine Cup

Preferred Volume

Urine, Random: 25 mL (Urine Cup)

Minimum Volume

Urine, Random: 10 mL (Urine Cup)

Specimen Collection and Handling

Collect random urine and send refrigerated in a clean, non-sterile urine container.

Specimen Stability Information

Specimen Type: Urine, Random

Refrigerated: 7 Days

Add On Capable

Not Permitted

Advance Beneficiary Notice Requirements

This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policies. Please verify that the diagnosis code (ICD code) you have chosen demonstrates medical necessity for the test as documented in the physician’s patient record. The CMS web site is available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD code chosen.

CPT Code Information

CPT Code

CPT Description

CPT Disclaimer

80307 Drug Test, Presumptive Screening, By Instrument Chemistry (i.e Immunoassay, Chromatography, and Mass Spectrometry)  
80367 Propoxyphene (Definitive), Quantitative if Indicated

Keywords

DRUGS OF ABUSE

Performing Laboratory Location

NorDx Laboratories

Maximum Laboratory Time

4 Days

LOINC Code Information

59734-4

Clinical Significance

If the propoxyphene screen is ≥ 300 ng/mL, the major metabolite, norpropoxyphene, will be confirmed by GC-MS at an additional charge.

Specific gravity, pH, creatinine and oxidants will be performed and reported at no additional charge to identify potential adulteration of the urine specimen.

This test is intended for clinical monitoring and management of patients. It is not intended for non-medical use such as employment or forensic testing.

Intended Positives:

Propoxyphene

Darvocet-N

Darvon, Novrad